Category: Diabetes
Global Diabetes
-
Global Diabetic Neuropathy Market 2023-2030
... to exhibit a CAGR of 6.7% during the forecast period (2024-2031). Diabetic neuropathy can be autonomic neuropathy, proximal neuropathy, focal neuropathy, and peripheral neuropathy. The growing market developments and increasing cases of diabetes among other ... Read More
-
2025 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Updated Analysis & Forecasts
... & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling endocrine, nutritional ... Read More
-
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) - Global Forecast to 2030
... age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role ... Read More
-
Global Type 2 Diabetes Market 2025-2029
... 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution Form, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Blood Glucose Monitoring Systems
... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring Systems, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$996.0 Million by the end ... Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2024-2030. Digital Diabetes Devices, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$46.7 Billion by the end ... Read More
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Diabetic Food
... CAGR of 4.8% over the analysis period 2024-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More
-
Insulin Pumps
... CAGR of 7.0% over the analysis period 2024-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Artificial Pancreas Device Systems
... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More
-
Continuous Glucose Monitoring Systems
... 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.4 Billion by the ... Read More
-
Diabetic Shoes
... CAGR of 8.1% over the analysis period 2024-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.6 Billion by the end of the ... Read More
-
Diabetic Footwear Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Medical Case Management Market - 2025 - 2033
... of 6.4% during the forecast period 2025-2033. Medical case management is a systematic approach to managing healthcare services for individuals with complex medical conditions or chronic illnesses. It involves assessing a patient's needs, planning and ... Read More
-
Global Incretin-Based Drugs Market - 2025 - 2032
... during the forecast period 2025-2032. Incretin-based drugs are a class of antidiabetic medications designed to mimic the effects of incretin hormones, which are naturally produced by the body to help regulate insulin secretion in response ... Read More
-
Global Diabetes Drugs Market - 2025 - 2032
... % during the forecast period 2025-2032. Diabetes is a chronic condition that arises when the pancreas either fails to produce sufficient insulin or when the body cannot effectively utilize the insulin it produces. Insulin is ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
... global generic drugs market size reached USD 389.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 674.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.66% during 2025-2033. The ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
2025 Global Forecast for Diabetic Footwear Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Infusion Devices Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps [Volumetric Pumps, Syringe Pumps, Insulin Pumps, Patient Control Analgesia (PCA) Pumps, Enteral Pumps, Implantable Pumps, and Elastomeric Pumps] and Infusion Sets [Vented Infusion Sets and Non-Vented Infusion Sets], Application (Diabetes, Oncology, Pain Management, Hematology, Pediatrics, Gastroenterology, and Others), End User (Hospitals and Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography
... the market growth include increasing prevalence of cancer and growing geriatric population. Further, strategic initiatives by market players are likely to boost the market during the forecast period. However, frequent product recalls of infusion devices ... Read More
-
Wearable Injectors Market by Type of Device (Patch Pump / On Body Injectors and Wearable Infusion Pump), Usability (Disposable and Reusable), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035
... Disorders) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035 Wearable Injectors Market: Overview As per Roots Analysis, the global wearable ... Read More
-
Global Stem Cell Therapy for Diabetes and Related Conditions Market Growth (Status and Outlook) 2024-2030
... was valued at US$ million in 2023. With growing demand in downstream market, the Stem Cell Therapy for Diabetes and Related Conditions is forecast to a readjusted size of US$ million by 2030 with a ... Read More
Research Assistance
